“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 25, no. 1, Dec. 2024, https://doi.org/10.7175/fe.v25i1.1568.